From Ulcer to Infection: An Update on Clinical Practice and Adjunctive Treatments of Diabetic Foot Ulcers

被引:5
|
作者
Abad, C. [1 ]
Safdar, N. [2 ]
机构
[1] Milwaukee Hlth Serv Inc, Early Intervent Program Clin, Milwaukee, WI USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Infect Dis Sect, Madison, WI 53705 USA
关键词
Diabetic foot infection; Diabetic foot ulcer; Antibiotics; G-CSF; COLONY-STIMULATING FACTOR; PRESSURE WOUND THERAPY; RANDOMIZED CONTROLLED-TRIAL; HYPERBARIC-OXYGEN THERAPY; SKIN-STRUCTURE INFECTIONS; VACUUM-ASSISTED CLOSURE; LOWER-EXTREMITY ULCERS; COMPLICATED SKIN; PIPERACILLIN-TAZOBACTAM; AMOXICILLIN-CLAVULANATE;
D O I
10.1007/s11908-012-0283-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Foot ulcers are a common complication of diabetes. A fifth of all individuals with diabetes develop a diabetic foot infection and are hospitalized at least once in their lifetime. Standard of care for treatment of diabetic foot ulcers and subsequent infection involves a multimodal, interdisciplinary team approach that includes wound care, systemic antimicrobials, and surgery. However, with the relatively poor outcome for chronic, longstanding ulcers and severe infections, recent research has focused on adjunctive therapies to promote wound healing and repair. This review summarizes the underlying pathology and classification of diabetic ulcers and focuses on recent advances that have important implications for the use of adjunctive therapy for diabetic foot infections.
引用
收藏
页码:540 / 550
页数:11
相关论文
共 50 条
  • [41] Effectiveness Of Foot Care Practice Tool On Diabetes Control Among Diabetic Patients With Risk For Foot Ulcers In South India
    Paihte, Rammuanpuii
    Jain, Timsi
    Sharmila, J.
    Vijayaraghavan, Rajagopalan
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 535 - 540
  • [42] Dysbiosis and diabetic foot ulcers: A metabolic perspective of Staphylococcus aureus infection
    Liu, Ruisi
    Feng, Jiawei
    Ni, Yiming
    Chen, Kaixin
    Wang, Yuqing
    Zhang, Ting
    Zhou, Mingmei
    Zhao, Cheng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [43] Differences in foot care practice between participants at risk for and with diabetic foot ulcers (DFUs) in community
    Hasanah, Uswatun
    Yusuf, Saldy
    Rachmawaty, Rini
    Mukhtar, Musdalifah
    Sandi, Serlina
    ENFERMERIA CLINICA, 2020, 30 : 144 - 148
  • [44] A model for diabetic foot ulcer clinical trials on advanced therapies
    Serena, Thomas
    Cole, Windy
    King, Emily
    JOURNAL OF WOUND CARE, 2024, 33 : S39 - S43
  • [45] Clinical Evaluation of Peripheral Vascular Disease in Diabetic Foot Ulcer
    Rathnaganpathi, T.
    Raghupathy, T.
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (06): : 312 - 318
  • [46] A Study on Prevalence, Profile, and Risk Factors of Developing Fungal Infection in Patients With Diabetic Foot Ulcer
    Azharuddin, S. K.
    Vijayakumar, Chellappa
    Nelson, Thirugnanasambandam
    Balasubramanian, Gopal
    Kumar, Nagarajan Raj
    Singh, Rakesh
    WOUND MANAGEMENT & PREVENTION, 2023, 69 (03) : 11 - 17
  • [47] The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice
    Bui, Ut T.
    Finlayson, Kathleen
    Edwards, Helen
    INTERNATIONAL WOUND JOURNAL, 2019, 16 (03) : 601 - 620
  • [48] Isolation and Characterization of New Bacteriophages against Staphylococcal Clinical Isolates from Diabetic Foot Ulcers
    Plumet, Lucile
    Morsli, Madjid
    Ahmad-Mansour, Nour
    Clavijo-Coppens, Fernando
    Berry, Laurence
    Sotto, Albert
    Lavigne, Jean-Philippe
    Costechareyre, Denis
    Molle, Virginie
    VIRUSES-BASEL, 2023, 15 (12):
  • [49] The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers
    Zimny, S
    Schatz, H
    Pfohl, M
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (04) : 191 - 194
  • [50] Risk Factors for Multidrug-Resistant Bacterial Infection in Diabetic Foot Ulcers
    Chen, Tian
    Yu, Jianhua
    Mu, Qi
    Wu, Ruibo
    Chang, Qi
    Ye, Jin
    Qian, Chao
    CLINICAL LABORATORY, 2024, 70 (11) : 2063 - 2070